Recruiting studies: Cardiomyopathy Secondary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Phase 2 · 1 location(s) · Lexeo Therapeutics · NCT07721025 Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy
Phase N/A · 6 location(s) · University of Athens · NCT06949748 Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy
NA · 6 location(s) · Institut d'Investigació Biomèdica de Bellvitge · NCT06474819 Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07516288 Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
Phase 4 · 1 location(s) · Medical University of Warsaw · NCT04654988 Characterization of priMary And sEcondary STress Related takOtsubo
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793008 Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Phase 1 · 3 location(s) · Sardocor Corp. · NCT06224660 END - VT Cohort Study
Phase N/A · 3 location(s) · Nova Scotia Health Authority · NCT05835791

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.